| 标题 |
42P TROP2 normalised membrane ratio (NMR) assessed by quantitative continuous scoring (QCS): Association with clinical outcomes with datopotamab deruxtecan (Dato-DXd) ± osimertinib (osi) in EGFR-mutated (EGFRm) NSCLC |
| 网址 | |
| DOI | |
| 其它 |
期刊:ESMO Open 作者:J. Sands; A.E. Lisberg; X. Le; E. Shum; L. Hendriks; et al 出版日期:2026-03-17 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)